-
-
-
-
-
-
-
IntelGenx Announces FDA’s Acceptance of Resubmitted RIZAPORT® New Drug Application
-
-
-
-
-
-
-
IntelGenx and RedHill Biopharma Resubmit RIZAPORT® New Drug Application to the FDA
-
-
-
-
-
-
-
RedHill Biopharma (RDHL), Grupo JUSTE Enter RIZAPORT Commercialization Term Sheet
-
15,434 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

